Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
AVEO > SEC Filings for AVEO > Form 8-K on 2-May-2013All Recent SEC Filings

Show all filings for AVEO PHARMACEUTICALS INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for AVEO PHARMACEUTICALS INC


2-May-2013

Other Events, Financial Statements and Exhibits


Item 8.01 Other Events.

On May 2, 2013, AVEO Pharmaceuticals, Inc. (the "Company") issued a press release announcing that the U.S. Food and Drug Administration's Oncologic Drugs Advisory Committee voted that the application for investigational agent tivozanib did not demonstrate a favorable benefit-to-risk evaluation for the treatment of advanced renal cell carcinoma in an adequate and well-controlled trial. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1 to this Current Report on Form 8-K.



Item 9.01 Financial Statements and Exhibits.

(d) The following exhibits are included in this report:

Exhibit
No. Description

99.1 Press release issued by the Company on May 2, 2013


  Add AVEO to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for AVEO - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.